ALK amplification has been detected in neuroblastoma, colorectal cancer and non-small cell lung cancer (NSCLC) (Salido et al., 2011; Bavi et al., 2013; Wang et al., 2013). This evidence concerns the gene ALK and non-small cell lung carcinoma.